Emphasis on Setting [Laboratory Testing and Point-of-Care (POC) Testing]; Indication (Myocardial Infarction, Acute Coronary Syndrome, Coronary heart disease, Congestive Heart Failure, and Other); End-Users (Hospitals, Diagnostic Centers, and Others); and Region/Country
The Cardiac troponin market was valued at USD 3,504.3 million in 2022 & is expected to grow at a CAGR of 10.2 % from 2023-2030. Cardiac troponins are proteins released into the bloodstream when the heart muscle is damaged, making them essential markers for diagnosing heart attacks and other cardiac conditions. The prevalence of cardiovascular diseases, such as heart attacks, heart failure, and myocardial infarctions, is a significant driver of the cardiac troponin market. As these conditions continue to affect a large portion of the population globally, the demand for troponin testing to diagnose and monitor these diseases remains high. For instance, in 2024, There are around 620 million people living with heart and circulatory diseases across the world. Globally it’s estimated that 1 in 13 people are living with a heart or circulatory disease. Furthermore, advances in technology have led to the development of more sensitive and specific troponin assays. These advancements improve the accuracy and reliability of troponin testing, driving adoption in clinical practice. Additionally, the aging population is more susceptible to cardiovascular diseases, leading to a higher demand for cardiac biomarker testing, including troponin.
Some of the major players operating in the market are F. Hoffmann-La Roche Ltd., BIOMÉRIEUX., Abbott, Siemens Healthcare Private Limited, Beckman Coulter, Inc, Trinity Biotech, Bio-Techne, PerkinElmer Inc, Bio-Rad Laboratories, Inc, Eurolyser Diagnostica GmbH. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst setting, the laboratory testing segment held a significant share of the market in 2023.”
Based on setting, the market is segmented into laboratory testing, point-of-care (poc) testing. The laboratory testing therapy category is expected to witness the highest CAGR during the forecast period. Laboratory-based troponin assays typically offer high accuracy and precision, making them well-suited for the diagnosis and monitoring of cardiovascular diseases. Healthcare providers often rely on laboratory testing to obtain precise troponin measurements, especially in cases requiring serial testing or when assessing patients with complex medical conditions. For instance, In 2021, ARCHITECT hsTnI I 20 assay. This high-sensitivity troponin I assay boasts improved precision and sensitivity for accurate heart attack diagnosis and exclusion. Additionally, Laboratory-based testing platforms offer comprehensive capabilities for cardiac biomarker testing, including troponin assays, alongside other relevant tests such as lipid profiles, electrolyte panels, and cardiac imaging.
“Amongst indication, the myocardial infarction segment held the higher CAGR in the market in 2023.”
Based on indication, the cardiac troponin market has been classified as myocardial infarction, acute coronary syndrome, coronary heart disease, congestive heart failure, and others. Among them, the myocardial infarction segment is expected to grow at a higher share in the market. Despite advancements in preventive cardiology and cardiovascular care, heart attacks remain a leading cause of morbidity and mortality globally. The aging population, rising prevalence of cardiovascular risk factors, such as hypertension, diabetes, and obesity, and lifestyle changes contribute to the increasing incidence of heart attacks, driving demand for troponin testing in the diagnosis and management of acute myocardial infarction.
“North America dominated the cardiac troponin market in 2023.”
The North America cardiac troponin market is expected to continue to grow in the coming years, driven by the increasing prevalence of cardiovascular disease and growing awareness of cardiac troponin among healthcare professionals and the general population, development of advanced techniques and the rise in treatment option. For instance, in 2019, according to CDC, Every year, about 805,000 people in the United States have a heart attack. About 1 in 5 heart attacks are silent, the damage is done, but the person is not aware of it.
Cardiac troponin Market Report Coverage
Reasons to buy this report:
Customization Options:
The global Cardiac troponin market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Impact Of Covid-19 On The Cardiac Troponin Market
6. Global Cardiac Troponin Market Revenue, 2020-2030f
7. Market Insights By Setting
8. Market Insights By Indication
9. Market Insights By End-users
10. Market Insights By Region
11. Cardiac Troponin Market Dynamics
12. Cardiac Troponin Market Opportunities
13. Cardiac Troponin Market Trends & Insights
14. Demand And Supply Side Analysis
15. Value Chain Analysis
16. Pricing Analysis
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Cardiac Troponin Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Cardiac troponin market were the three major steps undertaken to create and analyze the adoption of cardiac troponin in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Cardiac troponin market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Cardiac troponin market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Cardiac troponin market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as setting, indication, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Cardiac troponin market. Further, we conducted factor analysis using dependent and independent variables such as setting, indication, and end-user of the Cardiac troponin market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Cardiac troponin market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Cardiac troponin market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Cardiac troponin market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the setting, indication, and end-user in the global Cardiac troponin market.
The main objective of the Global Cardiac troponin Market Study
The current & future market trends of the global Cardiac troponin market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the current market size and growth potential of the global cardiac troponin market?
Q2: What are the driving factors for the growth of the global cardiac troponin market?
Q3: Which segment has the largest share of the global cardiac troponin market by setting?
Q4: What are the emerging technologies and trends in the global cardiac troponin market?
Q5: Which region will dominate the global cardiac troponin market?
Q6: Who are the key players operating in the global cardiac troponin market?
Customers who bought this item also bought